Diabetic neuropathy and plasma glucose control
- PMID: 7457487
- DOI: 10.1016/0002-9343(81)90426-5
Diabetic neuropathy and plasma glucose control
Abstract
Diabetic neuropathy is defined, and theories of its pathogenesis are reviewed. Recent studies designed to investigate the influence of plasma glucose on nerve function in noninsulin-dependent diabetic patients are summarized. Motor nerve conduction velocities in the median and peroneal nerves were measured using a double-stimulus technique, and sensory conduction velocity was measured by conventional methods before and after therapy with oral agents or insulin. The degree of hyperglycemia was assessed by measurement of fasting plasma glucose and glycosylated hemoglobin concentrations. The degree of slowing in motor nerve conduction velocity in untreated patients was found to correlate with the fasting plasma glucose and glycosylated hemoglobin concentrations, but sensory nerve function, although abnormal, did not show such correlation. Reduction of hyperglycemia was associated with improvement in motor nerve conduction velocity in the peroneal and median motor nerves of these patients, but sensory nerve conduction velocity showed no such improvement. Improvement in median motor nerve conduction velocity was directly related to the degree of reduction in fasting plasma glucose concentration. These findings suggest that metabolic factors related to hyperglycemia are important in the impaired motor nerve function seen in noninsulin-dependent patients with maturity-onset diabetes.
Similar articles
-
Nerve conduction abnormalities in untreated maturity-onset diabetes: relation to levels of fasting plasma glucose and glycosylated hemoglobin.Ann Intern Med. 1979 Mar;90(3):298-303. doi: 10.7326/0003-4819-90-3-298. Ann Intern Med. 1979. PMID: 426398
-
Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects.Ann Intern Med. 1981 Mar;94(3):307-11. doi: 10.7326/0003-4819-94-3-307. Ann Intern Med. 1981. PMID: 7013592
-
Effects of glycemic control and aldose reductase inhibition on nerve conduction velocity.Am J Med. 1985 Nov 15;79(5A):18-23. doi: 10.1016/0002-9343(85)90506-6. Am J Med. 1985. PMID: 3934964 Clinical Trial.
-
Complications: neuropathy, pathogenetic considerations.Diabetes Care. 1992 Dec;15(12):1902-25. doi: 10.2337/diacare.15.12.1902. Diabetes Care. 1992. PMID: 1464245 Review.
-
Role of neuropoietic cytokines in development and progression of diabetic polyneuropathy: from glucose metabolism to neurodegeneration.Exp Diabesity Res. 2003 Oct-Dec;4(4):303-12. doi: 10.1155/EDR.2003.303. Exp Diabesity Res. 2003. PMID: 14668051 Free PMC article. Review.
Cited by
-
Nerve conduction in children suffering insulin dependent diabetes mellitus.Indian J Pediatr. 2003 Dec;70(12):945-51. doi: 10.1007/BF02723816. Indian J Pediatr. 2003. PMID: 14719781
-
Daniel Porte Jr., 13 August 1931-13 May 2023.Diabetes. 2024 Jan 1;73(1):5-10. doi: 10.2337/db23-0787. Diabetes. 2024. PMID: 38118001 Free PMC article. No abstract available.
-
Ganglioside treatment in diabetic peripheral neuropathy: a multicenter trial.Acta Diabetol Lat. 1983 Jul-Sep;20(3):265-76. doi: 10.1007/BF02581271. Acta Diabetol Lat. 1983. PMID: 6356740 Clinical Trial.
-
Evaluation of thermal, pain, and vibration sensation thresholds in newly diagnosed type 1 diabetic patients.J Neurol Neurosurg Psychiatry. 1988 Nov;51(11):1420-4. doi: 10.1136/jnnp.51.11.1420. J Neurol Neurosurg Psychiatry. 1988. PMID: 3236020 Free PMC article.
-
Clinical and neurophysiological studies with the aldose reductase inhibitor, sorbinil, in symptomatic diabetic neuropathy.Diabetologia. 1984 Jun;26(6):445-8. doi: 10.1007/BF00262218. Diabetologia. 1984. PMID: 6432615 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical